Home » AVANIR PHARMACEUTICALS SAYS TO OFFER $20 MLN OF SHARES
AVANIR PHARMACEUTICALS SAYS TO OFFER $20 MLN OF SHARES
AVANIR Pharmaceuticals on Friday said it would sell $20 million of its common stock in a registered-direct offering to a select group of institutional investors. The company said it would sell about 6 million shares of Class A common stock at $3.35 per share. The net proceeds are expected to be about $19.4 million after offering expenses, the company said in a news release.
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
07May
-
14May
-
30May